• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    PREVALENCE OF VIROLOGICAL SUPPRESSION AND PATTERNS OF ACQUIRED HIV DRUG RESISTANCE AMONG INDIVIDUALS ON FIRST-LINE ANTIRETROVIRAL THERAPY IN FISHERFOLK COMMUNITIES IN UGANDA

    Thumbnail
    View/Open
    OMOOJA-CHS-MASTER.pdf (1.818Mb)
    Date
    2018-10-03
    Author
    Omooja, Jonah
    Metadata
    Show full item record
    Abstract
    Background: The UNAIDS targets sustained viral suppression among at least 90% of HIV individuals on antiretroviral therapy (ART), yet viral load (VL) monitoring is rarely done in resource-limited settings due to high costs. Objectives: We determined the prevalence of virological suppression, prevalence, and patterns of HIV-1 acquired drug resistance (ADR) and correlates of virological failure (VF) and ADR among Ugandan fisher-folk (FF) on first-line ART. Methods: We included HIV-1 infected participants aged ≥15 year on first-line antiretroviral therapy and stratified them by median duration on ART i.e. 6, 12, 24, 36 and ≥ 48 months. For VL testing, we implemented both a 10x10 matrix and a 5-mini-pool pooling strategies and a deconvolution algorithm to identify individuals with VF, defined as VL≥1000 RNA copies/ml. Individual samples with VF, were genotyped by Sanger sequencing, for HIV-1 ADR mutations. Correlates of VF and ADR were determined by logistic regression for p<0.05 and 95% confidence intervals. Results: Of 609 participants with median age of 35 years (IQR: 28-43), on first-line ART for a median duration of 22.7 (IQR: 8.9–36.4) months, 335 (55%) were female. The overall prevalence of virological suppression (VS) was 85.6% (521/609). We obtained sequences from 80 (90.9%) out of 88 participants with VF. Acquired drug resistance (ADR) was detected in 59 of 80 (73.6%) participants with successful resistance testing. Only being on ZDV+3TC+EFV/NVP regimen was significantly associated with VF, AOR 2.27 (1.37-3.74; p=0.001) while NNRTI mutations (p<0.001), being on ZDV+3TC+EFV/NVP regimen, AOR 6.42 (1.37-30.13, p=0.018) and VL≥10000 copies/ml, AOR 4.18 (1.25-14.05, p=0.02), and were correlates of ADR. Our pooling strategy for viral load testing saved 38.4% of VL testing cost and had a negative predictive value of 95.2% (samples with VL<1000 copies/ml as negatives). Conclusion: Prevalence of virological suppression among FF is high, but falls below UNAIDS 90% target, with higher prevalence of HIV-1 ADR among virological failures. A higher proportion of virological failures with no ADR suggests poor adherence. Integrated care strategies should include increased VL monitoring, introduction of potent PI-based 2nd-line regimen and adherence support. Adoption of pooling viral load testing could be useful in population monitoring of ART programmes.
    URI
    http://hdl.handle.net/10570/6895
    Collections
    • School of Bio-Medical Sciences (Bio-Medical) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV